Accriva Diagnostics recalls

Recall found. Accriva Diagnostics is named in FDA Class II recall Z-2460-2026 covering directCHECK ACT-LR whole blood quality control. Hazard: Assayed Whole blood control contains labeling with incorrect performance range. Identifying details: Lot #: A6DLA001 Unique Device Identifier: 10711234170373. Status: Ongoing.

Models with recalls

directCHECK ACT-LR whole blood quality control (1)

All Accriva Diagnostics recalls

FDA Class II · Medical device · June 24, 2026

directCHECK ACT-LR whole blood quality control recall — Accriva Diagnostics, Inc.

Assayed Whole blood control contains labeling with incorrect performance range.

Official ID Z-2460-2026 · Official record ↗

Verify with the official sources:

CPSC — consumer products ↗ (aggregated here)
NHTSA — vehicles, car seats, tires ↗ (aggregated here; use NHTSA's VIN lookup to check a specific vehicle)
FDA — food, drugs, medical devices ↗ (aggregated here)
USDA FSIS — meat, poultry & processed egg products ↗ (not aggregated here)
Recalls.gov — the U.S. government’s all-agency portal ↗

Found something wrong or missing? Report a data error.

Compiled from official public-domain government data. Last checked October 22, 2026 at 6:00 PM UTC.